Evidence map›Paper›PMID 42717002›Full record

ReviewPediatric nephrology (Berlin, Germany)2026

Adequacy of dialysis in children and adolescents: more than just Kt/V.

Fabio Paglialonga, Hiren P Patel

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pediatric nephrology (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Fabio PaglialongaPediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Hiren P PatelDivision of Pediatric Nephrology and Hypertension, Nationwide Children's Hospital, 700 Children's Dr, Columbus, OH, 43205, USA. hiren.patel@nationwidechildrens.org.ORCID http://orcid.org/0000-0003-4968-0943

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The concept of dialysis adequacy has evolved over time. Initially, the focus of dialysis adequacy was on the clearance of small molecules, namely urea. However, limitations of urea-based adequacy assessment and the importance of other elements have become increasingly recognized. There is growing evidence that removal of middle molecules is associated with improved clinical outcomes. Besides clearance of solutes, several clinical markers serve as measures of adequate dialysis. Phosphorus control can have many clinical benefits, but although phosphorus is a small molecule, the kinetics of phosphorus removal by dialysis are different than that of urea. Cardiovascular comorbidities and outcomes are heavily influenced by appropriate volume control, avoiding both excess fluid overload and volume depletion. Growth is an important outcome that does not correlate with urea clearance but may be better achieved using an intensified dialysis schedule and/or a modality that promotes removal of middle molecules. Rather than focusing solely on factors identified by the medical community, adequate dialysis should also address factors identified by patients and their families, including intradialytic and interdialytic symptoms, life participation, and quality of life. There is a bidirectional relationship between dialysis adequacy and both residual kidney function and dialysis access. Rather than applying a standard fixed prescription to all patients, there should be greater emphasis on personalizing the dialysis prescription using shared decision-making with the patient and family.

Indexed as

AdequacyAdolescentsChildrenClearanceDialysisPersonalization

Identifiers

PMID42717002

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.